Abstract |
The MTG-BT estimates the hydrolysis of triacyl-glycerols by pancreatic lipase, and appears attractive for monitoring exogenous lipase requirements in patients with exocrine pancreatic insufficiency. To assess the test's discrimination capacity and repeatability, 9 CF patients with PERT and 10 healthy children underwent the (13)C-MTG-BT twice, at a 2- to 4-week interval. The test distinguished well between patients with severe exocrine pancreatic insufficiency (SEPI) and healthy subjects. However, within-subject variability for postprandial per thousand(13)C-enrichment and postprandial % dose recovery (PDR) was high in both groups. Therefore, the (13)C-MTG-BT seems useful to distinguish between SEPI and normal exocrine pancreatic function, but requires further development to improve its repeatability.
|
Authors | Denise C Herzog, Edgard E Delvin, Caroline Albert, Jacques E Marcotte, Véronique A Pelletier, Ernest G Seidman |
Journal | Clinical biochemistry
(Clin Biochem)
Vol. 41
Issue 18
Pg. 1489-92
(Dec 2008)
ISSN: 1873-2933 [Electronic] United States |
PMID | 18817766
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Breath Tests
(methods)
- Child
- Cystic Fibrosis
(enzymology, therapy)
- Female
- Humans
- Lipase
(metabolism)
- Male
- Pancreas
(enzymology)
- Pilot Projects
- Reproducibility of Results
- Triglycerides
(chemistry, metabolism)
|